Consider a “best companies” approach to global investing
In light of the U.S. stock market’s dominance over the past decade, portfolio manager Rob Lovelace suggests an approach to investing in companies globally that de-emphasizes country of origin. Watch the full 2020 Outlook video from which this excerpt was taken for an opportunity to earn CE credit.
Advances in global biotech offer exciting opportunities
Innovative biotechnology companies — based both in and outside the United States — represent an exciting opportunity set, says portfolio manager Rob Lovelace.
U.S., China lead global growth slowdown
Slowing growth in both the U.S. and China is leading to tough economic times globally, says portfolio manager Rob Lovelace.